Skip Navigation

Promising Treatment for Long Covid

www.mdpi.com Targeting the High-Density Lipoprotein Proteome for the Treatment of Post-Acute Sequelae of SARS-CoV-2

Here, we target the high-density lipoprotein (HDL) proteome in a case series of 16 patients with post-COVID-19 symptoms treated with HMG-Co-A reductase inhibitors (statin) plus angiotensin II type 1 receptor blockers (ARBs) for 6 weeks. Patients suffering from persistent symptoms (post-acute sequela...

Targeting the High-Density Lipoprotein Proteome for the Treatment of Post-Acute Sequelae of SARS-CoV-2

They treated 16 patients with cholesterin and blood pressure medication and it showed a reduction of about 90 % in symptoms.

Here's an article in German about the study: https://www.hessenschau.de/gesellschaft/interview-marburger-post-covid-studie-zeigt-erstaunliche-erfolge-v1,cholesterin-long-covid-100.html

Can anyone gleen how bad the patients had it before treatment? I can't get further than the abstract in the full paper.

3
3 comments